Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Seong-bong Jo"'
Publikováno v:
Journal of the Korean Society of MR Technology. 29:17-22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29f7a5c192a074e5536e1a8e288723bb
https://doi.org/10.31159/ksmrt.2019.29.1.17
https://doi.org/10.31159/ksmrt.2019.29.1.17
Publikováno v:
Journal of the Korean Society of MR Technology. 28:9-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecacd0f397bf319d18f2ac2f06acd0c0
https://doi.org/10.31159/ksmrt.2018.28.1.9
https://doi.org/10.31159/ksmrt.2018.28.1.9
Autor:
Kushwaha Avadhesh S, Santanu Kundu, Seong Bong Jo, S. Narasimha Murthy, H.N. Shivakumar, Prashanth Manda
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 224
The purpose of the current study was to investigate the plausibility of delivery of ziconotide to the cerebrospinal fluid (CSF) via intranasal administration. Ziconotide was administered either in the form of solution or Kolliphor P 407 gels (KP 407)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0549521e98f7a56946daed7f9be4f388
https://pubmed.ncbi.nlm.nih.gov/26732557
https://pubmed.ncbi.nlm.nih.gov/26732557
Publikováno v:
Journal of Sport and Leisure Studies. 19:1455-1466
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::025e0ae784dbc96af43f18be9a543125
https://doi.org/10.51979/kssls.2003.05.19.1455
https://doi.org/10.51979/kssls.2003.05.19.1455
Publikováno v:
Archives of Pharmacal Research. 13:246-251
□Intermolecular interaction between barbiturates and membrane components such as phospholipid and cholesterol were investigated on1H-NMR spectra and infrared spectra. According to previous reports, barbiturates interacted with phospholipid through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::689bcba1995210cbf26129793eaf80b9
https://doi.org/10.1007/bf02856529
https://doi.org/10.1007/bf02856529